C43.4
Malignant melanoma of scalp and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant melanoma of the scalp and neck, classified under ICD-10 code C43.4, is a serious form of skin cancer that originates from pigment-producing cells called melanocytes. This type of melanoma is characterized by its occurrence on the scalp and neck regions, which are common sites for sun exposure. Recognizing the signs, understanding potential causes, and knowing available diagnostic and treatment options are crucial for effective management of this condition.
Causes & Symptoms
Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Presence of numerous or atypical moles on the scalp or neck. Genetic factors, including family history of melanoma or other skin cancers. Fair skin, light hair, and light eye color that are more susceptible to UV damage. Previous skin injuries or burns in the affected areas. Immunosuppression or compromised immune system conditions.
Key Symptoms: Changing moles in size, shape, or color on the scalp or neck. The appearance of a new, unusual pigmented lesion. Irregular borders or uneven color within a mole or lesion. Persistent itching, tenderness, or bleeding in a pigmented area. A mole or spot that looks different from other moles (the ‘A-B-C-D-E’ criteria: Asymmetry, Border irregularity, Color variation, Diameter over 6 mm, Evolving in appearance). Scalp or neck lesions that are raised or crusted. In some cases, ulceration or open sore in the affected area.
Diagnostic & Treatment
Diagnosis Path: Dermatological examination focusing on suspicious lesions. Dermoscopy, a non-invasive technique that provides a magnified view of skin structures to assess lesion characteristics. Biopsy of the lesion, which involves removing a small tissue sample for laboratory analysis to confirm malignancy. Imaging studies such as ultrasound, CT scans, or MRI might be ordered to check for local spread or metastasis if indicated.
Treatment Protocols: Surgical excision: The primary treatment involves surgically removing the tumor along with some surrounding healthy tissue to ensure complete removal. Sentinel lymph node biopsy: Performed to evaluate whether the cancer has spread to nearby lymph nodes. Immunotherapy: May be recommended for advanced disease to help the immune system recognize and attack melanoma cells. Targeted therapy: Utilized for melanomas with specific genetic mutations. Radiation therapy: Sometimes used in cases where surgical removal isn't feasible or to treat metastatic sites. Chemotherapy: Less commonly used but might be indicated for widespread or metastatic disease. Follow-up care: Regular skin checks and imaging are essential for detecting recurrences or metastasis early.
Clinical Advice & FAQs
Billing Guidance
Is C43.4 a billable ICD-10 code?
Yes, C43.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C43.4?
Clinical documentation must specify the nature of Malignant melanoma of scalp and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
